A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Nasim BAHAR, 387066

ROLE OF LAIR1 (CD305) IN FLOW CYTOMETRIC DETECTION OF OCCULT BONE MARROW INVOLVEMENT IN NON-CLL B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Sitaram Ghogale, 387068

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): REAL-WORLD DATA FROM LEBANON

EHA Library, Lewis Nasr, 387069

CLL IN AYA

EHA Library, Shehab Fareed Abdelgabber, 387071

PROGNOSTIC ANALYSIS OF GENE MUTATIONS ON TIME-TO-FIRST TREATMEN IN 93 NEWLY DIAGNOSED CHRONIC LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Xixi Xiang, 387073

PROGNOSTIC VALUE OF SERUM CREATININE TO CYSTATIN C RATIO AND ESTABLISHMENT OF A NOVEL RISK SCORE MODEL IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Zixun Yin, 387074

IBRUTINIB AS THIRD LINE THERAPY IN CLL PATIENTS, A 5-YEAR STUDY IN ALBANIA

EHA Library, Shaqir Qerama, 387077

BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY

EHA Library, Simona Bernardi, 387078

SARS-COV-2 OMICRON VARIANT INFECTION AND COVID-19 IN PERSONS WITH CHRONIC MYELOID LEUKAEMIA IN CHINA

EHA Library, Weiming Li, 387079

PSYCHIATRIC DISORDERS AS A FIRST MANIFESTATION OF SPORADIC CREUTZFELDT-JACOB DISEASE IN A PATIENT WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB: UNUSUAL AND LIFE THREATENING ASSOCIATION

EHA Library, Rachid Smaili, 387082

IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY

EHA Library, Ziyu Li, 387087

PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND CORONAVIRUS DISEASE 2019 IN THE OMICRON ERA

EHA Library, Feiyang Qi, 387088

LONG-TERM RESULTS OF THERAPY FOR CHRONIC MYELOID LEUKEMIA: A 20-YEAR ANALYSIS OF THE GIPAP PROGRAM IN RUSSIA

EHA Library, Oleg Shukhov, 387089

A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Weiming Li, 387090

MOLECULAR PATTERNS OF RESPONSE AFTER FRONTLINE TREATMENT IN CHRONIC MYELOID LEUKAEMIA ( CML).

EHA Library, Harberth Fernandez - Leyva, 387092

PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

EHA Library, Melissa Djodikromo, 387097

DATA INTEGRATION BETWEEN CLINICAL RESEARCH AND PATIENT CARE: A FRAMEWORK FOR CONTEXT-DEPENDING DATA SHARING AND IN SILICO PREDICTIONS

EHA Library, Ingo Roeder, 387098

ASC4KIDS: A MULTICENTER, OPEN-LABEL, PHASE 1B/2 STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

EHA Library, Hijiya Nobuko, 387099

EXPERIENCE OF FOUR LABORATORIES OF THE ITALIAN CML LABNET NETWORK IN THE USE OF THE CEPHEID CARTRIDGE SYSTEM

EHA Library, Barbara Izzo, 387100

EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF CHRONIC MYELOID LEUKEMIA : EXPERIENCE OF FATTOUMA BOURGUIBA HOSPITAL OF MONASTIR

EHA Library, Sana Lakhel, 387101

FIRST-LINE TREATMENT OUTCOMES OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IN A REAL-WORLD DATA SETTING IN LEBANON

EHA Library, Lewis Nasr, 387105

EVALUATION OF THE SECOND GENERATION TYROSINE KINASE INHIBITOR IN IMATINIB-RESISTANT OR -INTOLERANT CHRONIC PHASE, CHRONIC MYELOID LEUKEMIA ADULT PATIENTS

EHA Library, Soraya Bougherira, 387106

EXTRAMEDULLARY BLAST CRISIS PRESENTING AS INFILTRATIVE OPTIC NEURITIS: A TREATMENT DILEMMA

EHA Library, Nezille Joy Lina, 387107

GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY

EHA Library, Bruno Fattizzo, 387109

NEW MONOCYTE HEMATOLOGICAL PARAMETERS AS AN IMPORTANT INDICATOR OF MDS PATIENTS WITH POSITIVE OGATA SCORE - A PRELIMINARY STUDY

EHA Library, Alicja Dudzik, 387110

EXPRESSION OF NEO-201 MAY HELP IN THE DIFFERENTIAL DIAGNOSIS BETWEEN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Andrea Duminuco, 387112

CYTOGENETIC FEATURES OF 164 MOROCCAN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Yossra AGHOUTANE, 387115

TOBACCO SMOKING IN MDS PATIENTS – ANALYSIS FROM THE MDS PALG REGISTRY

EHA Library, Rafal Machowicz, 387118

A COMPREHENSIVE NGS PANEL APPROACH FOR CLINICAL GENOMIC ANALYSIS IN HAEMATOLOGICAL MALIGNANCY

EHA Library, joanne mason, 387119

CHRONIC MYELOMONOCYTIC LEUKEMIA AND CONCOMITANT MONOCLONAL GAMMOPATHY: A MULTICENTRE RETROSPECTIVE STUDY OF CLINICAL CHARACTERISTICS, PREVALENCE AND OUTCOME

EHA Library, Elisa Diral, 387123

AZACITIDINE IN COMBINATION WITH 14-DAY VENETOCLAX VERSUS AZACITIDINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS-2 IN CLINICAL PRACTICE SETTING

EHA Library, Andrius Žučenka, 387124

INTEGRATION OF TELEHEALTH IN DAILY CLINICAL PRACTICE IN PATIENTS WITH MYELODYSPLASTIC NEOPLASMS  - STATUS QUO AND FUTURE PERSPECTIVES

EHA Library, Reinhard Stauder, 387126

INCIDENCE OF DRUG-INDUCED MYELOSUPPRESSION AND ASSOCIATED ADVERSE EVENTS, QUALITY OF LIFE, AND MEDICAL RESOURCE USE IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Eduardo Sabate, 387127

TRANSFUSION BURDEN IS AN IMPORTANT PROGNOSTIC FACTOR IN LOWER-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Jungmin LEE, 387129

THE FREQUENCY, EVOLUTION AND SIGNIFICANCE OF GENE MUTATION IN MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE

EHA Library, Feng Xu, 387131

PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS

EHA Library, Guillermo Garcia-Manero, 387136

CLUSTERING OF COMORBIDITIES IS RELATED TO AGE AND SEX AND IMPACTS CLINICA1 OUTCOME IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE COHORT STUDY

EHA Library, TALBI FAIZA, 387141

CULTURAL DATA TO NEW CLASSIFICATION OF MYELODYSPLASTIC NEOPLASIA

EHA Library, Tamar Saralidze , 387142

ROLE OF MOLECULAR PROFILING IN MYELODYSPLASTIC SYNDROME IN REAL-WORLD - A NEW APPROACH IN MYELODYSPLASTIC SYNDROME’S RISK STRATIFICATION?

EHA Library, Duarte Pacheco Silva, 387143

EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.

EHA Library, Hanna Trubkina, 387144

ACQUIRED Α-THALASSEMIA IN A PATIENT WITH HIGH-RISK MYELODYSPLASTIC SYNDROME AND BONE MARROW FIBROSIS: CASE REPORT AND LITERATURE REVIEW

EHA Library, Eleni Gavriilaki, 387145

FACTORS ASSOCIATED WITH TRANSFUSION INDEPENDENCY POST TREATMENT IN HIGH RISK MDS PATIENTS

EHA Library, NAVEENA FATIMA, 387149

TARGETED SEQUENCING LANDSCAPE OF A CHINESE PURE RED CELL ANEMIA COHORT

EHA Library, Yue Li, 387151

REGULATION OF THE EGR2/FASL SIGNALING PATHWAY IS POTENTIALLY MEDIATED BY E3 UBIQUITIN PROTEIN LIGASE 2 IN BONE MARROW CELLS

EHA Library, Chenghao Jin, 387152

PERIPHERAL BLOOD CYTOPENIA, AN EARLY INDICATOR OF INBORN ERRORS OF IMMUNITY

EHA Library, Zivanai Cuthbert Chapanduka, 387153

NEW TERT VARIANT IN A FAMILY WITH APLASTIC ANEMIA

EHA Library, Marijana Virijevic, 387154

THE POTENTIAL MECHANISM OF TCM TREATMENT OF CHRONIC APLASTIC ANEMIA BASED ON DATA MINING AND NETWORK PHARMACOLOGY

EHA Library, Siyuan Cui, 387155

INFLAMMATORY MARKERS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS - A SINGLE CENTRE STUDY

EHA Library, Caroline Spaner, 387156

CLINICAL EFFECTIVENESS, TREATMENT USE, SATISFACTION AND IMPACT ON QUALITY-OF-LIFE OF PEGCETACOPLAN TREATMENT FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH).

EHA Library, Koo Wilson, 387159

FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA

EHA Library, Richard J Kelly, 387160

CHANGINGS IN GENETIC DEFINITION AND MANAGEMENT OF ACQUIRED APLASTIC ANEMIA: A SINGLE CENTER EXPERIENCE

EHA Library, Marta Bortolotti, 387162

THE EFFICACY OF HETROMBOPAG PLUS CYCLOSPORINE A IN PATIENTS WITH TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA: A PROSPECTIVE REGISTRY STUDY

EHA Library, Guangsheng He, 387164

COMPARISON OF CLINICAL CHARACTERISTICS OF CHILD AND ADULT PATIENTS WITH PNH: ——TEN-YEAR FOLLOW-UP

EHA Library, Hui Yang, 387165

NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY

EHA Library, Jon Salmanton-García, 387992

ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME

EHA Library, Tatyana Byalik, 387067

PROGNOSTIC SIGNIFICANCE OF CLINICAL INDICATORS RELATED TO AMINO ACID METABOLISM IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ming Liu, 387070

TWELVE CASES OF MULTICENTRIC CASTLEMAN DISEASE WITH ELEVATED SERUM IGG4 LEVELS AND INFILTRATING IGG4 POSITIVE PLASMA CELLS PATHOLOGICALLY FROM A SINGLE CENTER.

EHA Library, shishuo dai, 387072

ANALYSIS OF CLINICAL COURSE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND COMPLEX KARYOTYPE – SINGLE CENTRE EXPERIENCE

EHA Library, Sofija Sarac, 387075

PROGNOSTIC SIGNIFICANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGHV-U IN THE ERA OF NOVEL AGNETS; REAL-LİFE DATA

EHA Library, Fatma Arikan, 387076

INVOLVEMENT OF IMMUNITY IN THE CONTINUATION OF TFR AFTER BOSTINIB DISCONTINUATION

EHA Library, Yuki Fujioka, 387080

INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI

EHA Library, Silvia Marce Torra, 387081

COMPARISON OF CLINICO-HEMATOLOGICAL PARAMETERS AND MOLECULAR AND CYTOGENETIC RESPONSE OF TWO BCR-ABL FUSION TRANSCRIPTS IN CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB

EHA Library, Laabidi Baraa, 387083

INSIGHTS INTO RELAPSED AND REFRACTORY CHRONIC MYELOID LEUKEMIA: MOLECULAR-GENETIC, BIOCHEMICAL AND PROGNOSIS PATTERNS

EHA Library, Vasile Musteata, 387084

THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS

EHA Library, Susanne Isfort, 387085

EVALUATION OF A TRIAL OF IMATIB* DOSE TAPERING IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: RESULTS AT 4.5 YEARS

EHA Library, Naima Abdennebi, 387086

ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

EHA Library, Andreas Hochhaus, 387091

COMPARABLE B2A2/E13A2 AND B3A2/E14A2 REPORTING IN BCR-ABL ASSAY WHEN CALIBRATED BY WHO IS AND BY IVT-RNA COPY NUMBER

EHA Library, huilin wei, 387093

ABL1 GENE DNA SEQUENCING IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND PH+ ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Elena Kuzmina, 387094

SINGLE CENTER STUDY ON SARS-COV-2 INFECTION IN PATIENTS AFFECTED BY CML: VACCINATION STATUS AND BOSUTINIB THERAPY AS POSSIBLE PROTECTIVE FACTORS FOR HOSPITALIZATION.

EHA Library, Ivan Civettini, 387095

EVALUATION OF ANTIBODY RESPONSES AMONG FIVE DIFFERENT SARS-COV-2 VACCINES IN CHRONIC MYELOID LEUKEMIA PATIENTS – A REAL-WORLD STUDY

EHA Library, Ana Toreli, 387096

RELATIONSHIP BETWEEN REGULAR MOLECULAR MONITORING AND TREATMENT OUTCOMES IN CML PATIENTS IN ARMENIA

EHA Library, Lusine Harutyunyan, 387102

FACTORS ASSOCIATED WITH PROGRESSION-FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020

EHA Library, Claudia Sossa-Melo, 387103

FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020.

EHA Library, Claudia Sossa-Melo, 387104

STUDY ON THE RELATIONSHIP BETWEEN MDS AND ABNORMAL LIPID METABOLISM IN BONE MARROW MICROENVIRONMENT

EHA Library, yuchun li, 387108

PROTEOMIC ANALYSIS REVEALS AUTOPHAGY INHIBITION IN MYELODYSPLASTIC SYNDROMES

EHA Library, Georgia Tsekoura, 387111

COMPARISON OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES WITH HIGH AND LOW OGATA SCORE VALUES ON CYTOMETRY IN RELATION TO THE PRESENCE OF CYTOGENETIC ABNORMALITIES - A PRELIMINARY STUDY

EHA Library, Krzysztof Gawronski, 387113

THE USEFULNESS OF NEUTROPHIL NEW PARAMETERS ASSESSMENTS AS AN ELEMENT TO DISTINGUISH PATIENTS WITH GENETIC CHANGES IN MYELODYSPLASTIC SYNDROME - A PRELIMINARY STUDY

EHA Library, Katarzyna Kulik, 387114

TRISOMY 18 IN MYELODYSPLASTIC SYNDROMES

EHA Library, Nouha Bouayed Abdelmoula, 387116

AZACYTIDINE AND ALLOGENOUS STEM CELL TRANSPLANTATION IN LATE-ONSET ERYTHROPOIETIC PROTOPORPHYRIA

EHA Library, Daniel El Fassi, 387117

PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES- A SWEDISH RETROSPECTIVE REAL-WORLD STUDY

EHA Library, Frida Schain, 387120

ASSOCIATION OF GENE MUTATIONS AND CLINICAL MANIFESTATIONS AND PROGNOSIS IN  THE CLINICAL COHORT WITH 218 MDS PATIENTS

EHA Library, Zheng Ge, 387121

REAL-WORLD TREATMENT PATTERNS OF PATIENTS (PTS) WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (MDS) IN A US REAL-WORLD EVIDENCE DATABASE (COTA)

EHA Library, Rami S. Komrokji, 387122

MOLECULAR CLINICAL CHARACTERISTICS AND PROGNOSIS OF MDS PATIENTS WITH RUNX1 MUTATION

EHA Library, Nanfang Huang, 387125

FIRST-LINE TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES: A GLOBAL, RETROSPECTIVE OBSERVATIONAL COHORT STUDY

EHA Library, Amer M. Zeidan, 387128

DESCRIBING TREATMENT PATTERNS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME ACCORDING TO IPSS-R RISK CATEGORY

EHA Library, Ricardo Viana, 387130

DIAGNOSIS, CLASSIFICATION AND STRATIFICATION OF MYELODYSPLASTIC SYNDROMES IN ALGERIA

EHA Library, Yamina Bouchakour Moussa, 387133

HIGH SERUM FERRITIN LEVELS AT DIAGNOSIS PREDICT WORSE PROGNOSIS IN ADVANCED MDS IN CHILDREN.

EHA Library, chenmeng Liu, 387134

OUTCOMES OF PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Imen Ben Amor, 387137

PHASE 2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH MAGROLIMAB FOR PREVIOUSLY UNTREATED SUBJECTS WITH INTERMEDIATE TO VERY HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Amer M. Zeidan, 387138

ELTROMBOPAG IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA: A SINGLE-CENTER EXPERIENCE

EHA Library, AMAIA LOPEZ-PEÑA, 387139

THE LEVEL OF VASCULAR ENDOTHELIAL FACTOR (VEGF) IN THE BLOOD SERUM OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS RAEB I).

EHA Library, Halyna Starodub, 387140

ACQUIRED ALPHA THALASSEMIA IN ASSOCIATION WITH MYELODYSPLASTIC SYNDROME- A CASE REPORT

EHA Library, Priyavadhana Balasubramanian, 387146

HYPERCHROMIC ANEMIA AS THE FIRST MANIFESTATION OF MYELOPROLIFERATIVE DISEASE

EHA Library, sergey lepkov, 387147

NEXT GENERATION SEQUENCING IN MYELOID NEOPLASMS: DEVELOPING WORLD DATA FROM SINGLE CENTRE

EHA Library, Nida Anwar, 387148

ADVANCED CHRONIC MYELOMONOCYTIC LEUKEMIA IN ELDERLY AND FRAIL PATIENTS MANAGED BY AZACITIDINE IN THE FIELD OF CLINICAL PRACTICE.

EHA Library, Pasquale Niscola, 387150

LACTATE DEHYDROGENASE IS A PREDICTOR OF THROMBOEMBOLISM, AND THROMBOEMBOLISM IS A PREDICTOR OF DEATH, IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS FROM A KOREAN PNH REGISTRY

EHA Library, Jun Ho Jang, 387157

COMPARISON OF ELTROMBOPAG AND AVATROMBOPAG IN THE TREATMENT OF REFRACTORY/RELAPSED APLASTIC ANEMIA, A SINGLE CENTER STUDY IN CHINA

EHA Library, Zhuxin Zhang, 387158

USE OF ANAKINRA IN THE TREATMENT OF ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A SYSTEMATIC REVIEW

EHA Library, Ali Eshaghpour, 387161

HEMATOLOGIC RECOVERY INDUCED BY AVATROMBOPAG IN SAA REFRACTORY OR INTOLERANT TO IMMUNOSUPPRESSIVE THERAPY COMBINED WITH ELTROMBOPAG

EHA Library, Xiaoqing Liu, 387163

LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION

EHA Library, Pei Xuying, 387991